首页 › 肾癌（肾细胞癌） › 北卡罗来纳州 › Durham
Durham NC 肾癌（肾细胞癌）临床试验
12项针对 肾癌（肾细胞癌）的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
招募中1/2 期
- Duke Cancer Institute ( Site 5015), Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Durham VA Medical Center, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #12, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
招募中2 期
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- UNC- Chapel Hill, Chapel Hill · 距离 10 英里
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
招募中2 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
招募中3 期
- Duke University Medical Center, Durham
- Duke Cancer Center Southpoint, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
招募中1 期
- Xencor Investigative Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- Duke Cancer Center /ID# 251975, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
招募中1/2 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
其他城市的 肾癌（肾细胞癌）试验
- Houston, TX35 项研究
- New York City, NY27 项研究
- Dallas, TX23 项研究
- Nashville, TN23 项研究
- St. Louis, MO23 项研究
- Los Angeles, CA20 项研究
- Boston, MA16 项研究
- Baldwin Park, CA16 项研究
- Pittsburgh, PA15 项研究
- Philadelphia, PA15 项研究
- Queens, NY15 项研究
- Jacksonville, FL14 项研究
Durham的其他研究
- 乳腺癌64 项研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 急性髓系白血病33 项研究
- 转移性癌症33 项研究
- 前列腺癌32 项研究
- 肺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。